FDA advisers endorse new RSV antibody drug for babies

A panel of experts to the Food and Drug Administration has recommended the agency approve a long-acting antibody drug that can protect infants from the seasonal virus, RSV.

Related Keywords

Boston ,Massachusetts ,United States ,Missouri ,Jon Heinrichs ,Mary Anne Jackson ,Steven Krug ,Lindsey Baden ,Astrazeneca ,Northwestern University Feinberg School Of Medicine ,Drug Administration ,Antimicrobial Drugs Advisory Committee ,Advisory Committee On Immunization Practices ,Kansas City ,Northwestern University Feinberg School ,Drugs Advisory Committee ,Immunization Practices ,